Related Experiment Videos
Recent developments in depsipeptide research
1Department of Chemistry, North Carolina State University, Raleigh, NC 27695-8204, USA.
Current Medicinal Chemistry
|April 12, 2002
Summary
Recent advancements in depsipeptide research highlight their therapeutic potential. These compounds show promise as anticancer, antiviral, antifungal, and anti-inflammatory agents, with some in clinical trials.
Area of Science:
- Medicinal Chemistry
- Natural Products Chemistry
- Pharmacology
Background:
- Depsipeptides are bio-oligomers formed by hydroxy and amino acids.
- They possess diverse biological activities, including anticancer, antibacterial, antiviral, antifungal, and anti-inflammatory properties.
- Research since 1995 has significantly advanced the understanding of depsipeptides.
Purpose of the Study:
- To review major developments in depsipeptide research since 1995.
- To emphasize the biological properties and therapeutic potentials of depsipeptides.
- To discuss isolation, structural determination, and notable features of depsipeptides.
Main Methods:
- Literature review of depsipeptide research.
- Analysis of isolation and structural determination data.
- Evaluation of biological activities and therapeutic potential.
Main Results:
- Depsipeptides exhibit significant anticancer potential, with four in clinical trials.
- Antiviral depsipeptides like callipeltins and quinoxapeptins show activity against HIV.
- Antifungal, anti-inflammatory, and cardiovascular applications are also discussed, including compounds targeting opportunistic infections, neurokinin antagonism, and plasmin inhibition.
Conclusions:
- Depsipeptides represent a promising class of compounds with broad therapeutic applications.
- Further research into depsipeptides could lead to novel treatments for cancer, viral infections, and cardiovascular diseases.
- Specific depsipeptides are identified as potential lead compounds for drug development.